As of 2026-08-17, the Relative Valuation of ANI Pharmaceuticals Inc (ANIP) is 68.04 USD. This relative valuation is based on P/E multiples. With the latest stock price at 76.54 USD, the upside of ANI Pharmaceuticals Inc based on Relative Valuation is -11.1%.
The range of the Relative Valuation is 49.23 - 83.43 USD.
| Range | Selected | |
| Trailing P/E multiples | 10.3x - 12.3x | 11.3x |
| Forward P/E multiples | 18.3x - 18.9x | 18.6x |
| Fair Price | 49.23 - 83.43 | 68.04 |
| Upside | -35.7% - 9.0% | -11.1% |
| Date | P/E |
| 2026-08-14 | 16.08 |
| 2026-08-13 | 15.71 |
| 2026-08-12 | 15.78 |
| 2026-08-11 | 15.65 |
| 2026-08-10 | 15.91 |
| 2026-08-07 | 16.44 |
| 2026-08-06 | 17.36 |
| 2026-08-05 | 16.78 |
| 2026-08-04 | 16.64 |
| 2026-08-03 | 16.82 |
| 2026-07-31 | 16.64 |
| 2026-07-30 | 16.89 |
| 2026-07-29 | 17.18 |
| 2026-07-28 | 17.02 |
| 2026-07-27 | 16.46 |
| 2026-07-24 | 16.31 |
| 2026-07-23 | 16.49 |
| 2026-07-22 | 16.30 |
| 2026-07-21 | 16.63 |
| 2026-07-20 | 16.32 |
| 2026-07-17 | 16.64 |
| 2026-07-16 | 17.21 |
| 2026-07-15 | 16.98 |
| 2026-07-14 | 16.92 |
| 2026-07-13 | 17.03 |
| 2026-07-10 | 17.24 |
| 2026-07-09 | 17.60 |
| 2026-07-08 | 17.81 |
| 2026-07-07 | 18.06 |
| 2026-07-06 | 17.86 |
| 2026-07-02 | 18.07 |
| 2026-07-01 | 17.44 |
| 2026-06-30 | 17.39 |
| 2026-06-29 | 17.67 |
| 2026-06-26 | 17.75 |
| 2026-06-25 | 17.49 |
| 2026-06-24 | 17.37 |
| 2026-06-23 | 17.42 |
| 2026-06-22 | 16.93 |
| 2026-06-18 | 16.70 |
| 2026-06-17 | 16.91 |
| 2026-06-16 | 17.43 |
| 2026-06-15 | 17.28 |
| 2026-06-12 | 17.16 |
| 2026-06-11 | 17.15 |
| 2026-06-10 | 17.19 |
| 2026-06-09 | 17.06 |
| 2026-06-08 | 16.83 |
| 2026-06-05 | 17.04 |
| 2026-06-04 | 16.64 |